Abstract
Autophagy plays an important role in the occurrence, progression and treatment of cancer, neurodegenerative, autoimmune and inflammatory diseases. Recent years, autophagy has become a new hot spot in tumor area. Chronic myelogenous leukemia (CML) is a common hematopoietic malignancy; while autophagy is involved in its development, as well as targeting drug tyrosine kinase inhibitor resistance mechanisms, regulating autophagy provide a new direction for the treatment of CML. The intensive study of the relation between cell autophagy and cancer will help to overcome cancer. This article offers an up-to-date comprehensive review of autophagy and CML. Key words: Leukemia, myelogenous, chronic; Autophagy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
